These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 30582119)
1. Adjunctive Peony-Glycyrrhiza decoction for antipsychotic-induced hyperprolactinaemia: a meta-analysis of randomised controlled trials. Zheng W; Cai DB; Li HY; Wu YJ; Ng CH; Ungvari GS; Xie SS; Shi ZM; Zhu XM; Ning YP; Xiang YT Gen Psychiatr; 2018; 31(1):e100003. PubMed ID: 30582119 [TBL] [Abstract][Full Text] [Related]
2. Adjunctive aripiprazole for antipsychotic-related hyperprolactinaemia in patients with first-episode schizophrenia: a meta-analysis. Zheng W; Cai DB; Yang XH; Ungvari GS; Ng CH; Shi ZM; Hu ML; Ning YP; Xiang YT Gen Psychiatr; 2019; 32(5):e100091. PubMed ID: 31673677 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae-Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials. Zhang L; Qi H; Xie YY; Zheng W; Liu XH; Cai DB; Ng CH; Ungvari GS; Xiang YT Front Psychiatry; 2021; 12():728204. PubMed ID: 34658963 [TBL] [Abstract][Full Text] [Related]
6. Antiglucocorticoid and related treatments for psychosis. Garner B; Phillips LJ; Bendall S; Hetrick SE Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD006995. PubMed ID: 26725721 [TBL] [Abstract][Full Text] [Related]
7. Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Women With Schizophrenia: A Randomized Controlled Trial. Man SC; Li XB; Wang HH; Yuan HN; Wang HN; Zhang RG; Tan QR; Wong HK; McAlonan GM; Wang CY; Zhang ZJ J Clin Psychopharmacol; 2016 Dec; 36(6):572-579. PubMed ID: 27755159 [TBL] [Abstract][Full Text] [Related]
8. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive Melatonin for Tardive Dyskinesia in Patients with Schizophrenia: A Meta-Analysis. Sun CH; Zheng W; Yang XH; Cai DB; Ng CH; Ungvari GS; Li HY; Wu YJ; Ning YP; Xiang YT Shanghai Arch Psychiatry; 2017 Jun; 29(3):129-136. PubMed ID: 28904507 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. Pollok J; van Agteren JE; Carson-Chahhoud KV Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235 [TBL] [Abstract][Full Text] [Related]
20. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care. Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]